DOCSLIB.ORG

Financial Information As of March 31, 2010

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Financial Information As of March 31, 2010 Financial Information as of March 31, 2010 (The English translation of the “Yukashoken-Houkokusho” for the year ended March 31, 2010) Nissan Motor Co., Ltd. Table of Contents Page Cover...........................................................................................................................................................................1 Part I Information on the Company...........................................................................................................2 1. Overview of the Company .........................................................................................................................2 1. Key financial data and trends........................................................................................................................2 2. History ..........................................................................................................................................................4 3. Description of business .................................................................................................................................5 4. Information on subsidiaries and affiliates .....................................................................................................6 5. Employees...................................................................................................................................................13 2. Business Overview ......................................................................................................................................14 1. Overview of business results.......................................................................................................................14 2. Production, orders received and sales .........................................................................................................16 3. Issues and outlook for the fiscal year ahead................................................................................................17 4. Business and other risks..............................................................................................................................18 5. Important business contracts.......................................................................................................................21 6. Research and development activities ..........................................................................................................22 7. Analysis of financial position, operating results and cash flows.................................................................24 3. Equipment and Facilities..........................................................................................................................28 1. Overview of capital expenditures................................................................................................................28 2. Major equipment and facilities....................................................................................................................28 3. Plans for new additions or disposals ...........................................................................................................29 4. Corporate Information .............................................................................................................................30 1. Information on the Company’s shares ........................................................................................................30 2. Acquisition of treasury stock ......................................................................................................................47 3. Dividend policy...........................................................................................................................................48 4. Changes in the market price of the Company’s shares ...............................................................................48 5. Members of the Board of Directors and Statutory Auditors .......................................................................49 6. Corporate governance .................................................................................................................................52 5. Financial Information ...............................................................................................................................58 1. Consolidated Financial Statements .............................................................................................................59 (1) Consolidated financial statements...............................................................................................................59 (2) Other .........................................................................................................................................................126 2. Non-Consolidated Financial Statements ...................................................................................................127 (1) Non-consolidated financial statements......................................................................................................127 (2) Details of major assets and liabilities........................................................................................................148 (3) Other .........................................................................................................................................................149 6. Information on Transfer and Repurchase of the Company’s Stock ....................................150 7. Reference Information on the Company .........................................................................................151 Part II Information on Guarantors for the Company ....................................................................152 Independent Auditor’s Report .....................................................................................................................153 Internal Control Report..................................................................................................................................158 Confirmation Note.............................................................................................................................................160 【Cover】 【Document Submitted】 Securities Report (“Yukashoken-Houkokusho”) 【Article of the Applicable Law Requiring Article 24, Paragraph 1, of the Financial Instruments and Submission of This Document】 Exchange Law 【Filed to】 Director, Kanto Local Finance Bureau 【Date of Submission】 June 30, 2010 【Business Year】 111th Fiscal Term (from April 1, 2009, to March 31, 2010) 【Company Name】 Nissan Jidosha Kabushiki-Kaisha 【Company Name (in English)】 Nissan Motor Co., Ltd. 【Position and Name of Representative】 Carlos Ghosn, President 【Location of Head Office】 2, Takaracho, Kanagawa-ku, Yokohama, Kanagawa 【Phone No.】 (045) 461- 7410 【Contact for Communications】 Yukio Asada, Chief Manager, Consolidated Accounting Group, Accounting Division 【Nearest Contact】 1-1, Takashima 1-chome, Nishi-ku, Yokohama-shi, Kanagawa 【Phone No.】 (045) 523-5523 (switchboard) 【Contact for Communications】 Yukio Asada, Chief Manager, Consolidated Accounting Group, Accounting Division 【Place Where Available for Public Tokyo Stock Exchange, Inc. Inspection】 2-1, Nihonbashi Kabutocho, Chuo-ku, Tokyo - 1 - Part I Information on the Company 1. Overview of the Company 1. Key financial data and trends (1) Consolidated financial data Fiscal year 107th 108th 109th 110th 111th Year ended March 31, 2006 March 31, 2007 March 31, 2008 March 31, 2009 March 31, 2010 Millions Net sales 9,428,292 10,468,583 10,824,238 8,436,974 7,517,277 of yen Millions Ordinary income (loss) 845,872 761,051 766,400 (172,740) 207,747 of yen Millions Net income (loss) 518,050 460,796 482,261 (233,709) 42,390 of yen Millions Net assets 3,087,983 3,876,994 3,849,443 2,926,053 3,015,105 of yen Millions Total assets 11,481,426 12,402,208 11,939,482 10,239,540 10,214,820 of yen Net assets per share Yen 753.40 862.29 860.17 644.60 663.90 Basic net income (loss) per Yen 126.94 112.33 117.76 (57.38) 10.40 share Diluted net income per share Yen 125.96 111.71 117.56 ― ― Net assets as a percentage of % 26.9 28.6 29.4 25.6 26.5 total assets Return on equity % 18.66 13.89 13.68 (7.62) 1.59 Price earnings ratio Times 11.01 11.24 7.00 ― 77.02 Cash flows from operating Millions 757,869 1,042,827 1,342,284 890,726 1,177,226 activities of yen Cash flows from investing Millions (1,112,755) (1,114,587) (867,623) (573,584) (496,532) activities of yen Cash flows from financing Millions 457,919 106,912 (307,002) (135,013) (663,989) activities of yen Cash and cash equivalents at Millions 404,212 469,388 584,102 746,912 761,495 end of year of yen Employees 162,099 165,729 159,227 155,659 151,698 (21,257) (20,607) (21,308) (20,107) (17,600) ( ) represents the number of part-time Number employees not included in the above 165,397 169,299 163,099 160,422 157,624 numbers (21,564) (21,177) (21,686) (20,649) (17,908) Notes: 1. Net sales are presented exclusive of consumption tax. 2. Effective from the 108th fiscal year, the Company has adopted the Accounting Standard for Presentation of Net Assets in the Balance Sheet (ASBJ Statement No. 5) and the Implementation Guidance on the Accounting Standard for Presentation of Net Assets in the Balance Sheet (ASBJ Guidance No. 8) in the calculation of net assets. 3. Diluted net income per share for the 110th fiscal year is not presented because a net loss per
Load more

Recommended publications
  • Product Japan : Food Processing Sector - Health and Functional Foods Company Profiles
    Foreign Agricultural Service GAIN Report Global Agriculture Information Network Approved by: Date: 07/23/99 Sarah D. Hanson GAIN Report #JA9087 U.S. Embassy Market Brief - Product Japan : Food Processing Sector - Health and Functional Foods Company Profiles This report was prepared by the USDA’s Foreign Agricultural Service for U.S. exporters of food and agricultural products. This information is in the public domain and may be reprinted without permission. Use of commercial or trade names does not imply approval nor constitute endorsement by USDA/FAS. Tokyo[JA1], JA GAIN Report #JA9087 Page 1 of 24 Company Name Amway Japan Product Sector(s) Health and Functional Food Address 1-8-1, Shimo-Meguro Number Of Employees 728 Meguro-ku, Tokyo 153-8686 Number of Factories Overseas Contact Phone Number 03-5434-8484 Fax Number 03-5434-4923 Email Web Page Address www.amway.co.jp/amway_japan/ Contact Person Masura Iwata Executive Driector, External Affairs and Public Relations Sales and Net Profits Main Suppliers Year Sales (Mil. \) Net Profits 1995 177,991 22,424 1996 212,195 25,130 1997 203,361 26,638 Key Products % of Total Company Profile and Strategies Home Care Products 9 Japanese corporation of nonstore sales operator Amway (US). Housewares 30 Registered sales personnel involved in direct sales of detergents, Personal Care 34 cosmetics, kitchenware and nutritional supplements. Nutritional Supplements 23 Others 4 Main Brands Triple X (vitamin and mineral supplement), Nutri Protein, Acerola C (vitamin supplement), Salmon-Omega 3, Hon-E-Cece, Ironics, Beta Carotene A, Wheat Germ E. Main Ingredients Vitamins, protein concentrates, iron concentrates, calcium concentrates, beta caroten, wheat germ.
    [Show full text]
  • May 11, 2011 Company Name: Terumo Corporation Representative: Yutaro Shintaku, President Code No.: 4543, TSE Section 1 Inquirie
    May 11, 2011 Company name: Terumo Corporation Representative: Yutaro Shintaku, President Code No.: 4543, TSE Section 1 Inquiries: Tetsuya Kumei, General Manager, Corporate Communication / IR Dept. Notice Concerning the Renewal of a Policy for Large-scale Acquisitions of Terumo Shares (Takeover Defense Measures) In the Board of Directors held on April 30, 2008, Terumo Corporation decided upon the Company’s basic policy regarding those who control decisions on the Company’s financial and business policies. Giving consideration to this policy, the Company also decided upon introduction of policy for large-scale acquisitions of the Company’s shares (hereinafter referred to as the “Current Plan”) as a means to prevent decisions on the Company’s financial and business policies from being controlled by an inappropriate party. The Current Plan was approved by shareholders in the 93rd Annual General Meeting of Shareholders held on June 27, 2008. The effective period of the Current Plan is until the conclusion of the final Annual General Meeting of Shareholders in the business year ending no more than three years from the time of the conclusion of the 93rd Annual General Meeting of Shareholders. Based on consideration of recent trends in debate on takeover defense measures including amendments of the law since the Current Plan was implemented and the Corporate Value Study Group established by the Ministry of Economy, Trade and Industry, the Company reaffirmed that the current policy should be maintained in the Board of Directors held on May 11, 2011, and passed a resolution to make revisions to the Current Plan required by amendments to the law (the revised plan is hereinafter referred to as the “Plan”) and renew the Current Plan in the form of the Plan as a means to prevent decisions on the Company’s financial and business policies from being controlled by an inappropriate party.
    [Show full text]
  • FTSE Japan ESG Low Carbon Select
    2 FTSE Russell Publications 19 August 2021 FTSE Japan ESG Low Carbon Select Indicative Index Weight Data as at Closing on 30 June 2021 Constituent Index weight (%) Country Constituent Index weight (%) Country Constituent Index weight (%) Country ABC-Mart 0.01 JAPAN Ebara 0.17 JAPAN JFE Holdings 0.04 JAPAN Acom 0.02 JAPAN Eisai 1.03 JAPAN JGC Corp 0.02 JAPAN Activia Properties 0.01 JAPAN Eneos Holdings 0.05 JAPAN JSR Corp 0.11 JAPAN Advance Residence Investment 0.01 JAPAN Ezaki Glico 0.01 JAPAN JTEKT 0.07 JAPAN Advantest Corp 0.53 JAPAN Fancl Corp 0.03 JAPAN Justsystems 0.01 JAPAN Aeon 0.61 JAPAN Fanuc 0.87 JAPAN Kagome 0.02 JAPAN AEON Financial Service 0.01 JAPAN Fast Retailing 3.13 JAPAN Kajima Corp 0.1 JAPAN Aeon Mall 0.01 JAPAN FP Corporation 0.04 JAPAN Kakaku.com Inc. 0.05 JAPAN AGC 0.06 JAPAN Fuji Electric 0.18 JAPAN Kaken Pharmaceutical 0.01 JAPAN Aica Kogyo 0.07 JAPAN Fuji Oil Holdings 0.01 JAPAN Kamigumi 0.01 JAPAN Ain Pharmaciez <0.005 JAPAN FUJIFILM Holdings 1.05 JAPAN Kaneka Corp 0.01 JAPAN Air Water 0.01 JAPAN Fujitsu 2.04 JAPAN Kansai Paint 0.05 JAPAN Aisin Seiki Co 0.31 JAPAN Fujitsu General 0.01 JAPAN Kao 1.38 JAPAN Ajinomoto Co 0.27 JAPAN Fukuoka Financial Group 0.01 JAPAN KDDI Corp 2.22 JAPAN Alfresa Holdings 0.01 JAPAN Fukuyama Transporting 0.01 JAPAN Keihan Holdings 0.02 JAPAN Alps Alpine 0.04 JAPAN Furukawa Electric 0.03 JAPAN Keikyu Corporation 0.02 JAPAN Amada 0.01 JAPAN Fuyo General Lease 0.08 JAPAN Keio Corp 0.04 JAPAN Amano Corp 0.01 JAPAN GLP J-REIT 0.02 JAPAN Keisei Electric Railway 0.03 JAPAN ANA Holdings 0.02 JAPAN GMO Internet 0.01 JAPAN Kenedix Office Investment Corporation 0.01 JAPAN Anritsu 0.15 JAPAN GMO Payment Gateway 0.01 JAPAN KEWPIE Corporation 0.03 JAPAN Aozora Bank 0.02 JAPAN Goldwin 0.01 JAPAN Keyence Corp 0.42 JAPAN As One 0.01 JAPAN GS Yuasa Corp 0.03 JAPAN Kikkoman 0.25 JAPAN Asahi Group Holdings 0.5 JAPAN GungHo Online Entertainment 0.01 JAPAN Kinden <0.005 JAPAN Asahi Intecc 0.01 JAPAN Gunma Bank 0.01 JAPAN Kintetsu 0.03 JAPAN Asahi Kasei Corporation 0.26 JAPAN H.U.
    [Show full text]
  • Automobile Industry in India 30 Automobile Industry in India
    Automobile industry in India 30 Automobile industry in India The Indian Automobile industry is the seventh largest in the world with an annual production of over 2.6 million units in 2009.[1] In 2009, India emerged as Asia's fourth largest exporter of automobiles, behind Japan, South Korea and Thailand.[2] By 2050, the country is expected to top the world in car volumes with approximately 611 million vehicles on the nation's roads.[3] History Following economic liberalization in India in 1991, the Indian A concept vehicle by Tata Motors. automotive industry has demonstrated sustained growth as a result of increased competitiveness and relaxed restrictions. Several Indian automobile manufacturers such as Tata Motors, Maruti Suzuki and Mahindra and Mahindra, expanded their domestic and international operations. India's robust economic growth led to the further expansion of its domestic automobile market which attracted significant India-specific investment by multinational automobile manufacturers.[4] In February 2009, monthly sales of passenger cars in India exceeded 100,000 units.[5] Embryonic automotive industry emerged in India in the 1940s. Following the independence, in 1947, the Government of India and the private sector launched efforts to create an automotive component manufacturing industry to supply to the automobile industry. However, the growth was relatively slow in the 1950s and 1960s due to nationalisation and the license raj which hampered the Indian private sector. After 1970, the automotive industry started to grow, but the growth was mainly driven by tractors, commercial vehicles and scooters. Cars were still a major luxury. Japanese manufacturers entered the Indian market ultimately leading to the establishment of Maruti Udyog.
    [Show full text]
  • Tokyo Food Technology Week 2021
    Exhibit Brochure Tokyo Food Technology Week 2021 Sep. 2-3 2021 Sep. 2-3 2021 10:00～17:00 PACIFICO YOKOHAMA Exhibition Hall C [Website] https://tokyofoodtechnology.com/2021/en.pdf Organizer：EJK Japan, Ltd./ The Japan Food News Show profile The Gateway into Japan Market ! Tokyo Food Technology Week “Tokyo Food Technology Week” will be expandingly held by including “P & B JAPAN”, “Nutritious Food Ingredients EXPO”, and “food ingredients EXPO for Pre-packaged, Frozen, and Instant food”. TFTW creates the synergistic effect of 3 shows by proposing the cutting- edge technology that shows new trends in the whole food industry. LOGO nd NAME OF 2 Nutritious Food 1st food ingredients EXPO for Pre- 9th P&B JAPAN (P&B) SHOW Ingredients EXPO (NFI) packaged, Frozen, and Instant food (PFI) ORGANIZER(S) EJK Japan, Ltd. EJK Japan, Ltd./ The Japan Food News Food ingredients for bread Health functional food Food Ingredients (meat, & confectionery (flour, oil, ingredients (vitamin & sea food, vegetable, fruit, yeast, jam, honey, frozen mineral, oligo sugar, food cereal, seasoning, spice, dough, etc. ) / Food fiber, lactic acid bacteria, herb etc.) / Food additives ingredients for sandwich, sugar alcohol, protein, / Professional products for EXHBITOR burger (meat, vegetable, amino acid, enzyme, etc.) restaurant chain / Food PROFILE dairy product, sauce, etc. ) Vegetable / Herb / Honey processing technology / Coffee & tea & beverages product / Soy product / (freezing, thawing, / Kitchen equipment / POS Component analysis / sterilizer drying etc. )/ register
    [Show full text]
  • Albuminuria, Expression of Nicotinamide Adenine Dinucleotide
    991 Hypertens Res Vol.30 (2007) No.10 p.991-998 Original Article Albuminuria, Expression of Nicotinamide Adenine Dinucleotide Phosphate Oxidase and Monocyte Chemoattractant Protein-1 in the Renal Tubules of Hypertensive Dahl Salt-Sensitive Rats Shigemoto FUJII1), Ling ZHANG1), and Hiroaki KOSAKA1) In chronic renal diseases, experimental and human data suggest that excess albumin filtered through the glomerular capillary barrier is over-reabsorbed by proximal tubular cells, thereby activating these cells and upregulating the expression of chemokines. On the other hand, a high-salt diet has been shown to induce proteinuria in hypertensive Dahl salt-sensitive (DSS) rats, accompanied with the expression of reduced nic- otinamide adenine dinucleotide phosphate (NADPH) oxidase in the kidney. In the current study, we therefore examined albuminuria and the expressions of NADPH oxidase and monocyte chemoattractant protein-1 (MCP-1) in the renal tubular cells in hypertensive DSS rats, as well as the effects of the antioxidant N-ace- tylcysteine (NAC) on each of these parameters. DSS rats were fed a normal-salt diet (0.24% NaCl), a high- salt diet (8% NaCl), or a high-salt diet plus NAC supplementation (15 mg/mL drinking water) for 4 weeks. The high-salt diet provoked an increase in glomerular injuries accompanied with albuminuria and in urinary H2O2 and MCP-1 excretion. Immunohistochemical analysis showed the prominent expression of MCP-1 in the dilated tubular cells, where the NADPH oxidase subunit p47phox was also expressed. The current results suggest that albuminuria caused expression of NADPH oxidase and MCP-1 in the dilated renal tubules, resulting in interstitial inflammation and migration of mononuclear cells in DSS rats, because block- ade of albuminuria by NAC counteracted the p47phox and MCP-1 expression.
    [Show full text]
  • JPX-Nikkei Index 400 Constituents (Applied on August 31, 2021) Published on August 6, 2021 No
    JPX-Nikkei Index 400 Constituents (applied on August 31, 2021) Published on August 6, 2021 No. of constituents : 400 (Note) The No. of constituents is subject to change due to de-listing. etc. (Note) As for the market division, "1"=1st section, "2"=2nd section, "M"=Mothers, "J"=JASDAQ. Code Market Divison Issue Code Market Divison Issue 1332 1 Nippon Suisan Kaisha,Ltd. 3048 1 BIC CAMERA INC. 1417 1 MIRAIT Holdings Corporation 3064 1 MonotaRO Co.,Ltd. 1605 1 INPEX CORPORATION 3088 1 Matsumotokiyoshi Holdings Co.,Ltd. 1719 1 HAZAMA ANDO CORPORATION 3092 1 ZOZO,Inc. 1720 1 TOKYU CONSTRUCTION CO., LTD. 3107 1 Daiwabo Holdings Co.,Ltd. 1721 1 COMSYS Holdings Corporation 3116 1 TOYOTA BOSHOKU CORPORATION 1766 1 TOKEN CORPORATION 3141 1 WELCIA HOLDINGS CO.,LTD. 1801 1 TAISEI CORPORATION 3148 1 CREATE SD HOLDINGS CO.,LTD. 1802 1 OBAYASHI CORPORATION 3167 1 TOKAI Holdings Corporation 1803 1 SHIMIZU CORPORATION 3231 1 Nomura Real Estate Holdings,Inc. 1808 1 HASEKO Corporation 3244 1 Samty Co.,Ltd. 1812 1 KAJIMA CORPORATION 3254 1 PRESSANCE CORPORATION 1820 1 Nishimatsu Construction Co.,Ltd. 3288 1 Open House Co.,Ltd. 1821 1 Sumitomo Mitsui Construction Co., Ltd. 3289 1 Tokyu Fudosan Holdings Corporation 1824 1 MAEDA CORPORATION 3291 1 Iida Group Holdings Co.,Ltd. 1860 1 TODA CORPORATION 3349 1 COSMOS Pharmaceutical Corporation 1861 1 Kumagai Gumi Co.,Ltd. 3360 1 SHIP HEALTHCARE HOLDINGS,INC. 1878 1 DAITO TRUST CONSTRUCTION CO.,LTD. 3382 1 Seven & I Holdings Co.,Ltd. 1881 1 NIPPO CORPORATION 3391 1 TSURUHA HOLDINGS INC. 1893 1 PENTA-OCEAN CONSTRUCTION CO.,LTD.
    [Show full text]
  • Metropolis-Autumn-2020
    無料 PRICELESS Autumn 2020 Japan’s No.1 English Magazine www.metropolisjapan.com Scan this QR code to see the cover come alive! THANK YOU ALL! OUR OFFICIAL METROPOLIS SPONSORS e would like to thank all of Alex Iskounen Naoko Kinoshita our readers and friends for Andrew Peyton supporting us through this W extraordinary time. Andrew Smith Philippe Sauzedde Since 1994, Metropolis (formerly Tokyo Andrew Wheadon Classified) has been a free magazine at Sherwin Faden the heart of Japan’s international Bonson Lam community. In response to financial Brendan Ryan Reinhard Schu strains due to COVID-19, we launched a Bruce Corsino Richard Gruppetta crowdfunding campaign in August. We were amazed at how quickly people responded with donations, large Custom Media Robert Heldt or small. Your kind, supportive comments reaffirmed our mission, which David Clement Seth Sulkin has always been to serve the local David Richardson community through quality content, be David Swan Simon Farrell it about news, art, literature, film, music or advice for life in Japan. Frankie Hart Sunil Kulkarni Ian Newton Terrie Lloyd Joseph Lovullo Wolfgang Bierer Ken Kuroyanagi ...and many more Marc Fuoti Matthew Fawcett Melvin Dion Michael & Laycee Atkins Michael J For more information, visit gogetfunding.com/save-metropolis 6 CONTENT AUTUMN 2020 ABOUT TOWN Autumn Exhibitions 4 MUSIC Underground Japanese Musicians 6 FOCUS: UN/SEEN Living with a Stammer 10 Artist Goma 14 Photographer Paule Saviano 18 22 Kodomo Shokudo 22 COVER 14 READS A Family in PHOTO Hiroshima 26 Osaka Photographer & Video Director Headman_Tossy FILMMAKER Keishi Otomo 28 @headman_tossy MODEL Autumn Horoscope 33 Tokyo Vegan Girl Our Autumn Pick of Miyu Maemoto 10 28 18 Podcasts 34 @Meyou_Mae elcome to the Autumn 2020 and Japan.
    [Show full text]
  • TOBAM Maximum Diversification All World Developed Ex North America USD
    TOBAM Maximum Diversification All World Developed ex North America USD 31/12/2019 Instrument Weight BP PLC 0.10% IDEMITSU KOSAN CO LTD 0.21% INPEX HOLDINGS INC 0.07% JX HOLDINGS INC 0.09% NESTE OIL OYJ 1.16% OMV AG 0.08% SANTOS LTD 0.02% SBM OFFSHORE NV 0.05% TGS NOPEC GEOPHYSICAL CO ASA 0.02% VOPAK 0.02% WOOD GROUP (JOHN) PLC 0.02% AIR LIQUIDE 0.23% AIR WATER INC 0.02% AKZO NOBEL 0.12% ALUMINA LTD 0.03% AMCOR PLC-CDI 0.08% AVON RESOURCES LTD 0.53% BORAL LTD 0.02% CHR HANSEN HOLDING A/S 0.08% DAICEL CHEMICAL INDUSTRIES 0.02% DOWA HOLDINGS CO LTD 0.01% EMS-CHEMIE HOLDING AG-REG 0.03% FLETCHER BUILDING LTD 0.02% FORTESCUE METALS GROUP LTD 0.60% GIVAUDAN-REG 0.16% HITACHI CHEMICAL CO LTD 0.03% HUHTAMAKI OYJ 0.03% ISRAEL CHEMICALS LTD 0.02% JAMES HARDIE INDUSTRIES-CDI 0.07% JFE HOLDINGS INC 0.02% KANSAI PAINT CO LTD 0.03% KURARAY CO LTD 0.03% MITSUBISHI MATERIALS CORP 0.02% NEWCREST MINING LTD 1.35% TOBAM Maximum Diversification All World Developed ex North America USD 31/12/2019 Instrument Weight NIPPON PAINT CO LTD 0.05% NIPPON PAPER INDUSTRIES CO L 0.04% NIPPON SHOKUBAI CO LTD 0.01% NISSAN CHEMICAL INDUSTRIES 0.04% NOF CORP 0.02% NORTHERN STAR RESOURCES LTD 0.66% NOVOZYMES A/S-B SHARES 0.07% OJI PAPER CO LTD 0.03% ORICA LTD 0.02% ORORA LTD 0.02% SARACEN MINERAL HOLDINGS LTD 0.32% SMURFIT KAPPA GROUP PLC 0.04% SYMRISE AG 0.04% TAIHEIYO CEMENT CORP 0.02% TAIYO NIPPON SANSO CORP 0.02% TEIJIN LTD 0.02% THYSSENKRUPP AG 0.04% TORAY INDUSTRIES INC 0.02% WIENERBERGER AG 0.02% ADP 0.04% AENA SA 0.09% ALFA LAVAL AB 0.04% ALL NIPPON AIRWAYS CO LTD
    [Show full text]
  • THC005 Proceedings of ICALEPCS2009, Kobe, Japan
    THC005 Proceedings of ICALEPCS2009, Kobe, Japan THE IMPLEMENTATION OF THE SOFTWARE FRAMEWORK IN J-PARC/MLF T. Nakatani, Y. Inamura, T. Ito, S. Harjo, R. Kajimoto, M. Arai, JAEA/J-PARC, Tokai, Ibaraki, Japan T. Ohhara, H. Nakagawa, JAEA, Tokai, Ibaraki, Japan T. Aoyagi, JAEA, Taito-ku, Tokyo, Japan T. Otomo, J. Suzuki, T. Morishima, S. Muto, R. Kadono, S. Torii, Y. Yasu, KEK, Tsukuba, Ibaraki, Japan T. Hosoya, M. Yonemura, Ibaraki university, Hitachi, Ibaraki, Japan Abstract the computing environment of the instrument are limited. To perform neutron scattering experiments efficiently, it Therefore, we have decided to construct the software on a is necessary to use many kinds of software components common and flexible software framework. such as data acquisition (DAQ), equipment control, The whole information of the instruments should be analysis and visualization with ease-of-use and high recorded for maintenance. The parameters of the throughput environments. At accelerator-driven neutron measurement under various scanning conditions and the facilities with MW-class proton power, such as J-PARC analysis results associated with the measured raw data are (Japan Proton Accelerator Research Complex) and SNS also recorded as experimental meta-data in a database. (Spallation Neutron Source), data sizes are varied from The results of the simulation such as a first-principle several hundred MB to several ten GB per hour, calculation are also recorded in it. The experimental users depending on beamlines. Therefore, the software is can make use of this information before their experiments. necessarily scalable and flexible for the various The number of experimental users who visit J- experiments and the enormous data.
    [Show full text]
  • Introduction Objective Methods Results Summary References
    9042 Brigatinib in Japanese patients with anaplastic lymphoma kinase–positive non–small cell lung cancer: First results from the J-ALTA tyrosine kinase inhibitor-naive expansion cohort Masashi Kondo,1 Shunichi Sugawara,2 Toshihide Yokoyama,3 Toru Kumagai,4 Makoto Nishio,5 Koichi Goto,6 Yuichiro Ohe,7 Takashi Seto,8 Nobuyuki Yamamoto,9 Kentarou Kudou,10 Takayuki Asato,11 Pingkuan Zhang,12 Kazuhiko Nakagawa13 1Department of Respiratory Medicine, Fujita Health University School of Medicine, Toyoake, Japan; 2Department of Pulmonary Medicine, Sendai Kousei Hospital, Miyagi, Japan; 3Department of Respiratory Medicine, Kurashiki Central Hospital, Okayama, Japan; 4Department of Thoracic Oncology, Osaka International Cancer Institute, Osaka, Japan; 5Department of Thoracic Medical Oncology, The Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan; 6Department of Thoracic Oncology, National Cancer Center Hospital East, Kashiwa, Japan; 7Department of Thoracic Oncology, National Cancer Center Hospital, Tokyo, Japan; 8Department of Thoracic Oncology, National Hospital Organization Kyushu Cancer Center, Fukuoka, Japan; 9Internal Medicine III, Wakayama Medical University, Wakayama, Japan; 10Biostatistics, Japan Development Center, Takeda Pharmaceutical Company Limited, Osaka, Japan; 11Oncology Clinical Research Department, Oncology Therapeutic Area Unit for Japan and Asia, Takeda Pharmaceutical Company Limited, Osaka, Japan; 12Millennium Pharmaceuticals, Inc., Cambridge, MA, USA, a wholly owned subsidiary of Takeda Pharmaceutical
    [Show full text]
  • Istoxx® Mutb Japan Momentum 300 Index
    ISTOXX® MUTB JAPAN MOMENTUM 300 INDEX Components1 Company Supersector Country Weight (%) Z HOLDINGS Technology Japan 0.69 M3 Health Care Japan 0.65 KOEI TECMO HOLDINGS Technology Japan 0.65 MENICON Health Care Japan 0.59 CAPCOM Technology Japan 0.58 FUJITEC Industrial Goods & Services Japan 0.56 Ibiden Co. Ltd. Industrial Goods & Services Japan 0.56 NIPPON PAINT HOLDINGS Chemicals Japan 0.56 RENESAS ELECTRONICS Technology Japan 0.55 JEOL Industrial Goods & Services Japan 0.55 INTERNET INTV.JAPAN Technology Japan 0.53 JSR Corp. Chemicals Japan 0.52 NET ONE SYSTEMS Technology Japan 0.51 Fujitsu Ltd. Technology Japan 0.51 Bank of Kyoto Ltd. Banks Japan 0.51 Hokuhoku Financial Group Inc. Banks Japan 0.51 FUJITSU GENERAL Personal & Household Goods Japan 0.50 Iyo Bank Ltd. Banks Japan 0.50 Kyushu Financial Group Banks Japan 0.50 77 Bank Ltd. Banks Japan 0.49 COCOKARA FINE INC. Retail Japan 0.49 TOSHIBA TEC Industrial Goods & Services Japan 0.48 JCR PHARMACEUTICALS Health Care Japan 0.48 MONOTARO Retail Japan 0.48 COSMOS PHARM. Retail Japan 0.48 Tokyo Electron Ltd. Technology Japan 0.48 Nomura Research Institute Ltd. Technology Japan 0.48 Olympus Corp. Health Care Japan 0.47 SUNDRUG Retail Japan 0.47 Chiba Bank Ltd. Banks Japan 0.47 NEC NETWORKS & SY.INTG. Technology Japan 0.47 Nomura Holdings Inc. Financial Services Japan 0.47 TOKYO OHKA KOGYO Technology Japan 0.47 PENTA-OCEAN CONSTRUCTION Construction & Materials Japan 0.47 FUYO GENERAL LEASE Financial Services Japan 0.46 FUJI Industrial Goods & Services Japan 0.46 Hachijuni Bank Ltd.
    [Show full text]